돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 408554생성일: 2026년 10월 24일

Piperidine → 4-(1H-Indazol-5-yl)-2-methyl-5-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[b]pyridine-3-carbonitrile

https://huagongshe.com/ko/reaction/408554

반응식

참여 물질

역할이름HCID투입량
반응물PiperidineHCID 8082—
반응물3-Amino-2-butenenitrileHCID 70699—
반응물1,3-CyclopentanedioneHCID 77466—
반응물1H-Indazole-5-carboxaldehydeHCID 21250644—
용매EthanolHCID 702—
생성물4-(1H-Indazol-5-yl)-2-methyl-5-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[b]pyridine-3-carbonitrileHCID 46911319—

반응 단계

100 mg (1.026 mmol) cyclopentane-1,3-dione, 150 mg (1.026 mmol) 1H-indazole-5-carbaldehyde and piperidine (0.1 ml) in ethanol (8 ml) were heated to reflux for 4 h. The mixture was then evaporated to dryness, the remaining solid was dissolved in acetic acid (8 ml), and 84 mg (1.026 mmol) 3-aminobut-2-enenitrile were added. The solution was heated to reflux for 2 h. After cooling, the mixture was evaporated to dryness again, and the remaining solid was purified by preparative RP-HPLC (acetonitrile/water gradient) to yield 40 mg (13% of th.) of the title compound.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08759341B2
출처 데이터셋uspto-grants-2014_06
ORD IDord-85102133bed04a03b8ccf8bcb8679c11
출처 메모uspto-grants-2014_06